Ozan Alkan

2.5k total citations
11 papers, 336 citations indexed

About

Ozan Alkan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ozan Alkan has authored 11 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Ozan Alkan's work include Cancer therapeutics and mechanisms (3 papers), DNA Repair Mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). Ozan Alkan is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), DNA Repair Mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). Ozan Alkan collaborates with scholars based in United States, Canada and Germany. Ozan Alkan's co-authors include Helen M. Blau, Jason H. Pomerantz, Régis Doyonnas, Kostandin V. Pajcini, John C. Boothroyd, Melissa B. Lodoen, Ashley E. Fouts, Anita A. Koshy, Philippe Leboulch and Adam T. Palermo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Ozan Alkan

11 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ozan Alkan United States 8 206 58 54 48 46 11 336
Nils Pfaff Germany 8 271 1.3× 42 0.7× 30 0.6× 9 0.2× 16 0.3× 10 340
Andreas Werner Germany 11 521 2.5× 22 0.4× 38 0.7× 71 1.5× 144 3.1× 16 635
Sybil Hrstka United States 10 426 2.1× 11 0.2× 62 1.1× 110 2.3× 19 0.4× 15 529
Elizabeth Radley United Kingdom 7 338 1.6× 21 0.4× 70 1.3× 81 1.7× 91 2.0× 12 658
Rai Knee Canada 10 414 2.0× 11 0.2× 42 0.8× 143 3.0× 43 0.9× 10 610
Stefan Müller Germany 4 425 2.1× 18 0.3× 25 0.5× 33 0.7× 47 1.0× 5 598
Ya‐Chen Liang United States 9 283 1.4× 12 0.2× 29 0.5× 97 2.0× 81 1.8× 16 402
Siri Tvingsholm Denmark 7 215 1.0× 23 0.4× 169 3.1× 76 1.6× 106 2.3× 13 498
Angelika Kehlenbach Germany 8 545 2.6× 9 0.2× 38 0.7× 103 2.1× 28 0.6× 8 654
Jacques Thélu France 12 367 1.8× 13 0.2× 27 0.5× 170 3.5× 46 1.0× 20 544

Countries citing papers authored by Ozan Alkan

Since Specialization
Citations

This map shows the geographic impact of Ozan Alkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ozan Alkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ozan Alkan more than expected).

Fields of papers citing papers by Ozan Alkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ozan Alkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ozan Alkan. The network helps show where Ozan Alkan may publish in the future.

Co-authorship network of co-authors of Ozan Alkan

This figure shows the co-authorship network connecting the top 25 collaborators of Ozan Alkan. A scholar is included among the top collaborators of Ozan Alkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ozan Alkan. Ozan Alkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Koshkaryev, Alexander, Ozan Alkan, Lia Luus, et al.. (2019). Abstract 8: Targeting DNA-damage response pathway with a novel nano-liposomal ATR inhibitor in solid tumors. 8–8. 1 indexed citations
2.
Koshkaryev, Alexander, Ozan Alkan, Lia Luus, et al.. (2019). Abstract 8: Targeting DNA-damage response pathway with a novel nano-liposomal ATR inhibitor in solid tumors. Cancer Research. 79(13_Supplement). 8–8. 2 indexed citations
3.
Alkan, Ozan, Birgit Schoeberl, Alexander Koshkaryev, et al.. (2018). Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway. Science Signaling. 11(540). 19 indexed citations
4.
Godec, Jernej, Glenn S. Cowley, R. Anthony Barnitz, et al.. (2014). Inducible RNAi in vivo reveals that the transcription factor BATF is required to initiate but not maintain CD8 + T-cell effector differentiation. Proceedings of the National Academy of Sciences. 112(2). 512–517. 25 indexed citations
5.
Koshy, Anita A., Ashley E. Fouts, Melissa B. Lodoen, et al.. (2010). Toxoplasma secreting Cre recombinase for analysis of host-parasite interactions. Nature Methods. 7(4). 307–309. 63 indexed citations
6.
Palermo, Adam T., Régis Doyonnas, Nidhi Bhutani, et al.. (2009). Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. The FASEB Journal. 23(5). 1431–1440. 40 indexed citations
7.
Pajcini, Kostandin V., Jason H. Pomerantz, Ozan Alkan, Régis Doyonnas, & Helen M. Blau. (2008). Myoblasts and macrophages share molecular components that contribute to cell–cell fusion. The Journal of Cell Biology. 180(5). 1005–1019. 108 indexed citations
8.
Pomerantz, Jason H., et al.. (2008). Myoblasts and macrophages share molecular components that contribute to cell-cell fusion. The Journal of Experimental Medicine. 205(3). i7–i7. 2 indexed citations
9.
Dalle, B, Ozan Alkan, Peter Pasceri, et al.. (2004). eGFP reporter genes silence LCRβ-globin transgene expression via CpG dinucleotides. Molecular Therapy. 11(4). 591–599. 28 indexed citations
10.
Rivier, François, Ozan Alkan, Alan F. Flint, et al.. (2004). Role of bone marrow cell trafficking in replenishing skeletal muscle SP and MP cell populations. Journal of Cell Science. 117(10). 1979–1988. 27 indexed citations
11.
Mägert, Hans‐Jürgen, et al.. (1999). The Golden Hamster Aphrodisin Gene. Journal of Biological Chemistry. 274(1). 444–450. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nils Pfaff Breakdown of academic impact, for papers by Andreas Werner Breakdown of academic impact, for papers by Sybil Hrstka Breakdown of academic impact, for papers by Elizabeth Radley Breakdown of academic impact, for papers by Rai Knee Breakdown of academic impact, for papers by Stefan Müller Breakdown of academic impact, for papers by Ya‐Chen Liang Breakdown of academic impact, for papers by Siri Tvingsholm Breakdown of academic impact, for papers by Angelika Kehlenbach Breakdown of academic impact, for papers by Jacques Thélu
Rankless by CCL
2026